SPINK7 and head and neck squamous cell carcinoma: Serine peptidase inhibitor Kazal type 7 (SPINK7) has also been proposed as a prognostic factor also a molecular biomarker in HNSCC (Pennacchiotti et al., 2021; Du et al., 2022).